RNS Number : 4110X
Blackfinch Spring VCT PLC
25 April 2023
 

Blackfinch Spring VCT PLC (the "Company")

Issue of a Supplementary Prospectus

The Company announces that it has published a supplementary prospectus (the "Supplementary Prospectus") relating to the offer for subscription to raise up to £20 million together with an over-allotment facility of up to a further £10 million which the Company announced on 2 September 2022 (the "Offer").

 

The Supplementary Prospectus is a regulatory requirement under the Prospectus Regulation Rules and Section 87G of Financial Services and Market Act 2000 following the publication of the annual report and accounts for the year ended 31 December 2022 by the Company.

 

Copies of the Supplementary Prospectus and the Company's accounts for the year ended 31 December 2022 have been submitted to the Financial Conduct Authority and the Supplementary Prospectus will shortly be available for inspection at the National Storage Mechanism, which is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Copies of this Supplementary Prospectus together with the prospectus (containing details of the Offer) are available free of charge from the offices of the Company's investment manager, Blackfinch Investments Limited, at 1350-1360 Montpellier Court, Gloucester Business Park, Brockworth, Gloucester, Gloucestershire, GL3 4AH and the Company's website: https://blackfinch.ventures/vct.

 

25 April 2023

 

For further information, please contact:

 

Blackfinch Investments Limited (Investment Manager)

01452 717070

 

The City Partnership (UK) Limited (Company Secretary)

enquiries@city.uk.com

Robin Smeaton

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPSEMFFIEDSEDL